A Specific Activity‐Based Probe to Monitor Family GH59 Galactosylceramidase, the Enzyme Deficient in Krabbe Disease
- 20 December 2016
- journal article
- research article
- Published by Wiley in ChemBioChem
- Vol. 18 (4) , 402-412
Abstract
Galactosylceramidase (GALC) is the lysosomal β‐galactosidase responsible for the hydrolysis of galactosylceramide. Inherited deficiency in GALC causes Krabbe disease, a devastating neurological disorder characterized by accumulation of galactosylceramide and its deacylated counterpart, the toxic sphingoid base galactosylsphingosine (psychosine). We report the design and application of a fluorescently tagged activity‐based probe (ABP) for the sensitive and specific labeling of active GALC molecules from various species. The probe consists of a β‐galactopyranose‐configured cyclophellitol‐epoxide core, conferring specificity for GALC, equipped with a BODIPY fluorophore at C6 that allows visualization of active enzyme in cells and tissues. Detection of residual GALC in patient fibroblasts holds great promise for laboratory diagnosis of Krabbe disease. We further describe a procedure for in situ imaging of active GALC in murine brain by intra‐cerebroventricular infusion of the ABP. In conclusion, this GALC‐specific ABP should find broad applications in diagnosis, drug development, and evaluation of therapy for Krabbe disease.Keywords
This publication has 47 references indexed in Scilit:
- Crystal Structure of Human β-GalactosidaseJournal of Biological Chemistry, 2012
- Insights into Krabbe disease from structures of galactocerebrosidaseProceedings of the National Academy of Sciences, 2011
- Self‐Immobilizing Fluorogenic Imaging Agents of Enzyme ActivityAngewandte Chemie, 2010
- Activity-Based Profiling Reveals Reactivity of the Murine Thymoproteasome-Specific Subunit β5tChemistry & Biology, 2010
- Molecular Characterization of Mutations That Cause Globoid Cell Leukodystrophy and Pharmacological Rescue Using Small Molecule Chemical ChaperonesThe Journal of Neuroscience, 2010
- Pathogenesis of leukodystrophy for Krabbe disease: Molecular mechanism and clinical treatmentBrain and Development, 2009
- Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTipsNature Protocols, 2007
- A Strategy for Functional Proteomic Analysis of Glycosidase Activity from Cell LysatesAngewandte Chemie, 2004
- Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure–function studies of lysosomal β-galactosidase and the non-lysosomal β-galactosidase-like proteinBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1999
- Substrate specificities of the two genetically distinct human brain β-galactosidasesBrain Research, 1977